Israeli drug company Neurim Pharmaceuticals has lost a bid to patent a mini version of its melatonin tablet Circadin for children, after a successful challenge by Australian drug maker Generic Partners.
The Albanese government has succeeded in advancing labor reforms that it says will strengthen access to wage bargaining, encourage job security and gender equity, and bolster the role of the Fair Work Commission.
Vanguard Investments has coughed up almost $40,000 for allegedly misleading investors about funds that purportedly did not invest in companies that sell or manufacture tobacco.
US lingerie and beauty giant Victoria’s Secret has won undertakings from Chemist Warehouse to stop selling allegedly fake fragrance products until a trade mark suit against the pharmacy giant is decided.
Property data analytics firm CoreLogic is taking aim again at a lawsuit accusing it of unauthorised scraping of confidential information from building information provider BCI Media’s copyright-protected leads platform, months after a judge found the case was “defective and deficient”.
The president of the Administrative Appeals Tribunal has resigned only eight months after her appointment to the top job by the former federal government.
News outlet Crikey has handed over internal documents showing its plans to mount a marketing campaign portraying itself as the victim in a “David and Goliath” battle with Fox News CEO Lachlan Murdoch over an allegedly defamatory article about the January 6 attack on the US Capitol, a court has heard.
AUSTRAC has filed Federal Court action against Star Entertainment, alleging “widespread and serious non-compliance” with anti-money laundering laws.
A “massive dispute about privilege” is on the cards in the defamation row between Fox News CEO Lachlan Murdoch and news outlet Crikey over an article about the January 6 attack on the US Capitol.
The maker of Vagisil personal care products has filed a trade mark suit against pharmaceuticals and cosmetic company Dr Wolff over its new line of Vagisan products, arguing the name is likely to confuse consumers.